View of Cyclophosphamide, thalidomide and dexamethasone (CTD) as first-line therapy in multiple myeloma patients : an experience in a clinical haematology centre in Dakar, Senegal

Return to Article Details Cyclophosphamide, thalidomide and dexamethasone (CTD) as first-line therapy in multiple myeloma patients : an experience in a clinical haematology centre in Dakar, Senegal Download Download PDF